Bu, S., Royston, L., Mabanga, T., Berini, C. A., Tremblay, C., Lebouché, B., . . . Routy, J. (2024). Proteomics validate circulating GDF-15 as an independent biomarker for COVID-19 severity. Frontiers in Immunology, 15, . https://doi.org/10.3389/fimmu.2024.1377126
Chicago Style (17th ed.) CitationBu, Simeng, et al. "Proteomics Validate Circulating GDF-15 as an Independent Biomarker for COVID-19 Severity." Frontiers in Immunology 15 (2024). https://doi.org/10.3389/fimmu.2024.1377126.
MLA (8th ed.) CitationBu, Simeng, et al. "Proteomics Validate Circulating GDF-15 as an Independent Biomarker for COVID-19 Severity." Frontiers in Immunology, vol. 15, 2024, https://doi.org/10.3389/fimmu.2024.1377126.
Warning: These citations may not always be 100% accurate.
Visit our Citation Styles guide for help on properly citing sources.
Visit our Citation Styles guide for help on properly citing sources.